In summary, despite the above-mentioned limitations, the present study provides evidence that the GSTM1, GSTT1 and GSTP1 polymorphisms are not associated with the development of RCC in the overall analysis. This evidence concerns the gene GSTM1 and renal cell adenocarcinoma.